MoneyWorks4Me

Astec Lifesciences concludes sale of its 100% stake in ACCPL

18 Feb 2016 Evaluate

Astec Lifesciences has completed the sale of 100% of the total paid-up equity share capital held in ACCPL to Ashok Hiremath and Varun Hiremath. Consequent to the completion of the sale, ACCPL has ceased to be a subsidiary of the company.

Astec Lifesciences is a producer of agrochemicals and pharmaceutical intermediates. It was established in 1994 with a focus on the Agrochemical and Pharmaceutical industries.



Astec Lifesciences Share Price

607.30 -10.35 (-1.68%)
12-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 570.00
PI Industries 2483.00
Bayer CropScience 4110.45
Sharda Cropchem 798.70
Sumitomo Chem. India 547.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: